Maravai LifeSciences Holdings Inc expected to post a loss of 4 cents a share - Earnings Preview

Maravai Lifesciences Holdings

04/08/2026 23:43

Maravai LifeSciences Holdings Inc MRVI.OQ MRVI.O is expected to  show a rise in quarterly revenue when it reports  results on August 6 for the period ending June 30 2026
The San Diego California-based  company is expected to report a 2.7% increase in revenue to $48.683 million from $47.4 million a year ago, according to the mean estimate from 8 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Maravai LifeSciences Holdings Inc is for a loss of 4 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Maravai LifeSciences Holdings Inc is $6.00, about 6.7% below its last closing price of $6.43
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.04
-0.05
0.01
Beat
121.2
Dec. 31 2026
-0.08
-0.07
-0.04
Beat
43.6
Sep. 30 2025
-0.09
-0.08
-0.08
Met
2​
Jun. 30 2025
-0.07
-0.07
-0.08
Missed
-12.8
​​Mar. 31 2025
-0.07
-0.07
-0.08
Missed
-12
Dec. 31 2024
-0.04
-0.04
-0.06
Missed
-50​
Sep. 30 2024
-0.01
-0.01
-0.02
Missed
-160.1
Jun. 30 2024
0.00
0.00
0.00
Met
-100
This summary was machine generated August 4 at 22:43 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)